Dr Stone is a Senior Research Fellow in infectious disease modelling at the Bristol Medical School, University of Bristol. His research focuses on the use of mathematical modelling to project the impact of interventions on transmission of hepatitis C virus and HIV among people who inject drugs.

Trang Nguyen is the program manager of Harm reduction and Addiction treatment at SCDI - a Vietnamese leading NGO. She has 10 years experience in all aspects of drug use scene in Vietnam, from developing model of community harm reduction and treatment, capacity building for community-based organizations to policy advocacy.

Lucas Martignetti is a Research Coordinator at the Centre on Drug Policy Evaluation and is currently pursuing a PhD in Health Sciences at Ontario Tech University. His research focuses on overdose prevention and health inequity. He has also been a been a harm reduction worker and volunteer.

Andrew Ivsins uses qualitative and community-based methods to explore how socio-structural factors shape social and health inequities experienced by people who use drugs and people living with HIV. His current work has focused on impacts of the unregulated drug supply and innovative responses to the ongoing overdose crisis.

Magdalena Harris is Professor of Inclusion Health Sociology at the London School of Hygiene & Tropical Medicine. She draws on her lived experience to lead a programme of work aiming to improve harm reduction services and access to care for people who use crack cocaine and heroin in the UK.

Dr. Myat Kay Khine is Deputy Director of AHRN and one of the technical supervisors who leads the medical intervention of the largest harm reduction organization in Myanmar, and she has more than 7 years of experience in the harm reduction field.

Dr Lise Lafferty is a Senior Research Fellow with a co-appointment across the Centre for Social Research in Health, and the Kirby Institute, at UNSW Sydney. Her research interests include improving health outcomes of people who inject drugs in prison, with a focus on hepatitis C.

Marianne Alanko Blomé, MD, Ph.D, is an Infectious Disease specialist and medical supervisor of the Needle Exchange Program at the ID department of Skane University hospital in Malmo, Skane Region, Sweden. She also serves as Assistant Medical Officer at the Regional Office of Communicable Disease Control and Prevention, Region Skane.

Dr. Elaine Hyshka is an Associate Professor and Canada Research Chair in Health Systems Innovation at the University of Alberta’s School of Public Health, and Scientific Director of the Inner City Health and Wellness Program. Her research is focused on advancing a public health approach to substance use in Canada.

Scott Elliott is the CEO of Vancouver’s Dr. Peter Centre. He joined in 2017 and brings 35+ years experience designing & implementing innovative programs in the non-profit sector. Scott has lived experience with HIV, Hep C and addiction fuelling a deep desire to make positive transformative change.

Prof. Stéphanie Baggio, PhD, is a senior epidemiologist and head of the Statistics and Methodology Unit at the Institute of Primary Health Care (BIHAM) at the University of Bern. She leads and supervises projects on health inequalities and preventive medicine, with the main aim of improving access to health care.

Dr Sophia Schroeder is a qualitative researcher with expertise in qualitative and mixed methods research and using social theory to address barriers to wellbeing among marginalised groups. She is a postdoctoral Research Officer at Burnet Institute working on multiple projects within Disease Elimination and Implementation Science.